Potentiation of erythropoiesis
CA 1329762 C · Owner: The Salk Institute For Biological Studies · Inventors: Rivier, Jean Edouard Frederic; Yu, Alice Lin-Tsing; Vaughan, Joan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of the Disclosure A method for modulating the rate of, erythropoiesis in human hematopoietic progenitor cells. FRP is found to be an efficacious potentiator of and, inhibin a suppressor of, erythropoietin-induced differentiation. FRP and inhibin are shown to be functional antagonists of each other, and thus represent an effective means for modulating erythropoiesis in a number of disease states which are directly caused by or associated with an abnormal rate of erythropoiesis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 24, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 24, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.